Strategic Approaches for Developing Alternative Tests for Safety and Potency of Vaccines Fulltext Access 8 Pages 2011
Toward replacement of the monkey neurovirulence test in vaccine safety testing Fulltext Access 5 Pages 2011
Target alternative vaccine safety testing strategies for pertussis toxin Fulltext Access 13 Pages 2011
Veterinary vaccine post-licensing safety testing: overview of current regulatory requirements and accepted alternatives Fulltext Access 12 Pages 2011
Application of the consistency approach to reduce animal use in vaccine potency testing Fulltext Access 4 Pages 2011
Development and validation of serological methods for human vaccine potency testing: Case study of an anthrax vaccine Fulltext Access 8 Pages 2011
Animal Refinement and Reduction: Alternative Approaches for Potency Testing of Diphtheria and Tetanus Vaccines Fulltext Access 13 Pages 2011
Overview of Currently Approved Serological Methods with a Focus On Diphtheria and Tetanus Toxoid Potency Testing Fulltext Access 8 Pages 2011
A case study of development, validation, and acceptance of a non-animal method for assessing human vaccine potency Fulltext Access 8 Pages 2011
Case study of development, validation, and acceptance of a non-animal method for assessing veterinary vaccine potency Fulltext Access 9 Pages 2011
Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use Fulltext Access 4 Pages 2011
International regulatory requirements for vaccine safety and potency testing: a WHO perspective& Fulltext Access 7 Pages 2011
The International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: introduction and summary Fulltext Access 15 Pages 2011
European Regulatory Requirements for Veterinary Vaccine Safety and Potency Testing and Recent Progress Towards Reducing Animal Use Fulltext Access 5 Pages 2011
Alternative Methods to Reduce, Refine, and Replace the Use of Animals In the Development and Testing of Veterinary Biologics in The United States; a Strategic Priority Fulltext Access 5 Pages 2011
U.S. FDA requirements for Human Vaccine Product Safety and Potency Testing Fulltext Access 4 Pages 2011
Veterinary Vaccines and Their Importance to Animal Health and Public Health Fulltext Access 10 Pages 2011
Alternative methods and strategies to reduce, refine, and replace animal use for veterinary vaccine post-licensing safety testing: state of the science and future directions Fulltext Access 14 Pages 2011
Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions Fulltext Access 22 Pages 2011
Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions Fulltext Access 24 Pages 2011
Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions Fulltext Access 13 Pages 2011
Improving animal welfare and reducing animal use for human vaccine potency testing: state of the science and future directions Fulltext Access 14 Pages 2011
Non-animal replacement methods for human vaccine potency testing: state of the science and future directions Fulltext Access 17 Pages 2011